speb/financial-data huggingface dataset:
RELAXO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 18550500000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 18231100000.00
RELAXO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 13170287.13
RELAXO.NS income_statement (annual, 2023-03-31) — Tax Provision: 555400000.00
RELAXO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
RELAXO.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 295600000.00
RELAXO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -554900000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 24947900000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 18550500000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1640800000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 18550500000.00
RELAXO.NS income_statement (annual, 2023-03-31) — Total Expenses: 25483700000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 6397400000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 13011600000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1690900000.00
RELAXO.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 25600000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 496900000.00
RELAXO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 49800000.00
RELAXO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 49800000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 933900000.00
RELAXO.NS balance_sheet (annual, 2023-03-31) — Working Capital: 7229800000.00
RELAXO.NS income_statement (annual, 2023-03-31) — Write Off: 1300000.00
RELAXO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 13999200000.00
RELAXO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 28936000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 2582700000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3577400000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5701200000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 2168300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -32100000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Amortization: 102700000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 102700000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 2000000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 248938586.00
RELAXO.NS income_statement (annual, 2024-03-31) — Basic EPS: 8.05
RELAXO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 102700000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 7343500000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2493900000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 1864300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 248900000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 403500000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1692100000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -622300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 270100000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 133400000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -346900000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -269600000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 145500000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Change In Payable: 17500000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -862400000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -1151000000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 300800000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 248900000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -622300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 20011100000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 410500000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 12279000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 12463900000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 360000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Current Debt: 185400000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 545400000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 5194500000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 401000000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Depreciation: 1372200000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1474900000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1474900000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1474900000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 249042317.00
RELAXO.NS income_statement (annual, 2024-03-31) — Diluted EPS: 8.05
RELAXO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 2004700000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 3700000.00
RELAXO.NS income_statement (annual, 2024-03-31) — EBIT: 2878100000.00
RELAXO.NS income_statement (annual, 2024-03-31) — EBITDA: 4353000000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 0.00
RELAXO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 403500000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 245900000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -1064100000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 3267400000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -142700000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -93900000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 25100000.00
RELAXO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 541800000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 227000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3609500000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 19603200000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Gross Profit: 16657000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 700000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Interest Expense: 185400000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 185400000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Interest Income: 126100000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 126100000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -186300000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 115600000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Inventory: 5988000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 20196500000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -986300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 247900000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 3428000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 1504300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1504300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 191800000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 6295000000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -7900000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Net Income: 2004700000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 2004700000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 2004700000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 2004700000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 2004700000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 2692700000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 2004700000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -10300000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Net Interest Income: -84100000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 1359500000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 185400000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -84100000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 13902000000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -2451100000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 185400000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 19784100000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 237400000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 296900000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 4270400000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Normalized Income: 1943204764.73
RELAXO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2351200000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Operating Income: 2657800000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 28936000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 248938586.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 677500000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 61900000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 227000000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 31600000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 175200000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 500000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 5574300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 770700000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 2126200000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 351500000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 1288600000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Other Special Charges: -4100000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Payables: 3858000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 348200000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Pretax Income: 2692700000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -24200000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -10300000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -2483600000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1890700000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 12279000000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1474900000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 95700000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 938800000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 32500000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 2700400000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 3242200000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 248938586.00
RELAXO.NS income_statement (annual, 2024-03-31) — Special Income Charges: -14300000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 57100000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 20011100000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 19784100000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 21104764.73
RELAXO.NS income_statement (annual, 2024-03-31) — Tax Provision: 688000000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
RELAXO.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 409000000.00
RELAXO.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -668300000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Total Assets: 27139100000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 20011100000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2049700000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 20011100000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Total Expenses: 26278200000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 7128000000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 14675200000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1933500000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 24800000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 500900000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 82600000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 82600000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Work In Process: 829900000.00
RELAXO.NS balance_sheet (annual, 2024-03-31) — Working Capital: 7269400000.00
RELAXO.NS income_statement (annual, 2024-03-31) — Write Off: 18400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2467200000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 3119800000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 672400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 2106100000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 248900000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 171400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1558600000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 248900000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 20109400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 461600000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 12225800000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 440000000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 12400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 452400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 5041600000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 520300000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 179300000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 13922600000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 6695100000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 20121800000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 672400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 1666100000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1666100000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 194800000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 13922600000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 19930100000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 212900000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 248938586.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 846500000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 675900000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 19860500000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 179300000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 223900000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 13461000000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 5800000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1387200000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Payables: 2556200000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 248938586.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 20109400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 19930100000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 27224800000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 20109400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2118500000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 20109400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 7115400000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 14999000000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 2073800000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 89000000.00
RELAXO.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 7184200000.00
RELAXO.NS income_statement (annual, 2025-03-31) — +Operating Expense: 14171100000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 3091100000.00
RELAXO.NS income_statement (annual, 2025-03-31) — +Total Revenue: 27896100000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 6951500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2001200000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2001200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 3120500000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3120500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -6738700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6738700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 2168300000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2168300000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -38400000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -38400000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Amortization: 99500000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 99500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 2000000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 2000000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 249020468.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 248761062.00
RELAXO.NS income_statement (annual, 2025-03-31) — Basic EPS: 6.84
RELAXO.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 2.26
RELAXO.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 403500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 7743200000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 7743200000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1158300000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 2125200000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2125200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 248900000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 248900000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 223700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 223700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2915100000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2915100000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -746800000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 149900000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 149900000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 73800000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 73800000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 408300000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 548100000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -186600000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Change In Payable: -577100000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 452600000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 764000000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -179800000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Common Stock: 248900000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 248900000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 20980700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 20980700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 777600000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 777600000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 11489300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3133600000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Current Assets: 12346000000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 12346000000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 439400000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 439400000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Current Debt: 0.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 0.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 439400000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 439400000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 4508200000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4508200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 461200000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 461200000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Depreciation: 1584300000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1584300000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1584300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 393700000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 1584300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 393700000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 249020468.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 248761062.00
RELAXO.NS income_statement (annual, 2025-03-31) — Diluted EPS: 6.84
RELAXO.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.26
RELAXO.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1703300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 562200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 4000000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 4000000.00
RELAXO.NS income_statement (annual, 2025-03-31) — EBIT: 2505300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — EBIT: 807700000.00
RELAXO.NS income_statement (annual, 2025-03-31) — EBITDA: 4089600000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1201400000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
RELAXO.NS cash_flow (annual, 2025-03-31) — End Cash Position: 223700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 736700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 736700000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -1619600000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 3198600000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3198600000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 2901800000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -94300000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
RELAXO.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 432500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 136700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 136700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3158900000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3158900000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 20828600000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 20828600000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Gross Profit: 16406800000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 3817900000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 0.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 0.00
RELAXO.NS income_statement (annual, 2025-03-31) — Interest Expense: 206600000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 54100000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 206600000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 54100000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Interest Income: 90100000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 90100000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -207200000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 99500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Inventory: 5575900000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 5575900000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 20980700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 20980700000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -2620300000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 738700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 738700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 3493600000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 3493600000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 1685800000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1685800000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1685800000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1685800000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 211300000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 211300000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 6414700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 6414700000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -3200000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Net Income: 1703300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Net Income: 562200000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1703300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 562200000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1703300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 562200000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1703300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 562200000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1703300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 562200000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 2298700000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1703300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 562200000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -9300000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Net Interest Income: -206600000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -54100000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1793500000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -185400000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -206600000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -54100000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 219500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Net PPE: 14089900000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 14089900000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1136500000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -185400000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 20844000000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 20844000000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 233200000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 233200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 312400000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 312400000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 4089600000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1201400000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Normalized Income: 1703300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 562200000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 4060100000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Operating Income: 2235700000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Operating Income: 726800000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Operating Revenue: 27896100000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 6951500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 248938586.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 248938586.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 4400000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 4400000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 775300000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 775300000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 1700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 136700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 136700000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 75400000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 348100000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 348100000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 269600000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 80900000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 8581300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1809600000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Payable: 665200000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 665200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Properties: 2399500000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 2399500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 46100000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 46100000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 2691400000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2691400000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Other Special Charges: -30800000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Payables: 3197700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Payables: 3197700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 225400000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 225400000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Pretax Income: 2298700000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 753600000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -9300000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1149000000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1533900000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1533900000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 11489300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3133600000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1584300000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 393700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 196900000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 196900000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1145300000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1145300000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 12500000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 2496300000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2928800000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 248938586.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 248938586.00
RELAXO.NS income_statement (annual, 2025-03-31) — Special Income Charges: 23200000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 0.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 20980700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 20980700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 20844000000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 20844000000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RELAXO.NS income_statement (annual, 2025-03-31) — Tax Provision: 595400000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 191400000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
RELAXO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
RELAXO.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 261700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 261700000.00
RELAXO.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -576200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 27624700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 27624700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 20980700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 20980700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2125200000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2125200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 20980700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 20980700000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Total Expenses: 25660400000.00
RELAXO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 6224700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 6644000000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 6644000000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 15278700000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15278700000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2135800000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2135800000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 30500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 527300000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 527300000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 119200000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 119200000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 5500000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 5500000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 843400000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 843400000.00
RELAXO.NS balance_sheet (annual, 2025-03-31) — Working Capital: 7837800000.00
RELAXO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 7837800000.00
RELAXO.NS income_statement (annual, 2025-03-31) — Write Off: 7600000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 3449400000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 6544900000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 249489796.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.96
RELAXO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2497500000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 396500000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 396500000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 249489796.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.96
RELAXO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 489000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — EBIT: 711200000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — EBITDA: 1107700000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 4047400000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 52100000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 52100000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Net Income: 489000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 489000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 489000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 489000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 489000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 489000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -52100000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -52100000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1107700000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 489000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Operating Income: 598000000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 6544900000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 113200000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1997800000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 659100000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2497500000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 396500000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 170100000.00
RELAXO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
RELAXO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 5946900000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 3417000000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 6285400000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2585000000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2731500000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 2271000000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 247671233.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.46
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2125000000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 248900000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 13300000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2549300000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 248900000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 21094900000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 746400000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2450400000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 11883500000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 464400000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 29700000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 494100000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5518400000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 677500000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 393600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 393600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 247671233.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.46
RELAXO.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 361600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — EBIT: 540600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — EBITDA: 934200000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 102300000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 14004600000.00